Effect of Botulinum Toxin in the Treatment of Drooling: A Controlled Clinical Trial
- 1 September 2004
- journal article
- clinical trial
- Published by American Academy of Pediatrics (AAP)
- Vol. 114 (3), 620-627
- https://doi.org/10.1542/peds.2003-1104-l
Abstract
Objective. To investigate the clinical effectiveness of botulinum neurotoxin type A (BoNT) to reduce drooling in children with cerebral palsy (CP).Keywords
This publication has 32 references indexed in Scilit:
- The Treatment of Drooling by Ultrasound‐Guided Intraglandular Injections of Botulinum Toxin Type A Into the Salivary GlandsThe Laryngoscope, 2003
- Botulinum Toxin to Reduce Saliva Flow: Selected Indications for Ultrasound‐Guided Toxin Application Into Salivary GlandsThe Laryngoscope, 2002
- EFFECT OF ANTIREFLUX MEDICATION ON SALIVARY DROOLING IN CHILDREN WITH CEREBRAL PALSYDevelopmental Medicine and Child Neurology, 1996
- LONG‐TFRM OUTCOME OF SALIVA‐CONTROL SURGERYDevelopmental Medicine and Child Neurology, 1995
- TRANSDERMAL SCOPOLAMINE FOR REDUCTION OF DROOLING IN DEVELOPMENTALLY DELAYED CHILDRENDevelopmental Medicine and Child Neurology, 1994
- Effect of repeated sampling and prestimulation on saliva buffer capacity and flow rate values in childrenEuropean Journal of Oral Sciences, 1991
- The Surgical Management of DroolingDevelopmental Medicine and Child Neurology, 1991
- USE OF BENZHEXOL HYDROCHLORDE TO CONTROL DROOLING OF CHILDREN WITH CEREBRAL PALSYDevelopmental Medicine and Child Neurology, 1990
- Drooling and its Management in Cerebral PalsyDevelopmental Medicine and Child Neurology, 1987
- Drool Control: Long‐term Follow‐upDevelopmental Medicine and Child Neurology, 1980